Pages that link to "Q56990573"
Jump to navigation
Jump to search
The following pages link to Kazuo Takayama (Q56990573):
Displaying 50 items.
- Generation of Brain Microvascular Endothelial-Like Cells from Human Induced Pluripotent Stem Cells by Co-Culture with C6 Glioma Cells (Q28548080) (← links)
- Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system. (Q33701667) (← links)
- Efficient and directive generation of two distinct endoderm lineages from human ESCs and iPSCs by differentiation stage-specific SOX17 transduction (Q33961501) (← links)
- Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX. (Q34556886) (← links)
- Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes. (Q34601581) (← links)
- HHEX promotes hepatic-lineage specification through the negative regulation of eomesodermin. (Q35126482) (← links)
- Expression of coxsackievirus and adenovirus receptor separates hematopoietic and cardiac progenitor cells in fetal liver kinase 1-expressing mesoderm (Q35552087) (← links)
- Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction. (Q35665145) (← links)
- Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine (Q36272752) (← links)
- Long-term self-renewal of human ES/iPS-derived hepatoblast-like cells on human laminin 111-coated dishes (Q37360935) (← links)
- Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells (Q37513377) (← links)
- Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells (Q37620655) (← links)
- Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection. (Q37736696) (← links)
- Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells (Q38293285) (← links)
- Hepatic maturation of human iPS cell-derived hepatocyte-like cells by ATF5, c/EBPα, and PROX1 transduction. (Q38294717) (← links)
- Laminin 411 and 511 promote the cholangiocyte differentiation of human induced pluripotent stem cells. (Q38776304) (← links)
- Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xL Mutant Gene. (Q38997397) (← links)
- Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening (Q39052831) (← links)
- Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction (Q39338143) (← links)
- The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets (Q39374697) (← links)
- Adenovirus vector-mediated efficient transduction into human embryonic and induced pluripotent stem cells (Q39665198) (← links)
- Hepatitis C virus-induced innate immune responses in human iPS cell-derived hepatocyte-like cells (Q40046934) (← links)
- Inhibition of CRISPR/Cas9-Mediated Genome Engineering by a Type I Interferon-Induced Reduction in Guide RNA Expression (Q40312489) (← links)
- Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection (Q43042479) (← links)
- 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing (Q45231872) (← links)
- Direct conversion of human fibroblasts into hepatocyte-like cells by ATF5, PROX1, FOXA2, FOXA3, and HNF4A transduction (Q47218544) (← links)
- CCAAT/enhancer binding protein-mediated regulation of TGFβ receptor 2 expression determines the hepatoblast fate decision (Q47951369) (← links)
- Generation of Optogenetically Modified Adenovirus Vector for Spatiotemporally Controllable Gene Therapy (Q48254450) (← links)
- Enrichment of high-functioning human iPS cell-derived hepatocyte-like cells for pharmaceutical research (Q50110957) (← links)
- Isolation and expansion of human pluripotent stem cell-derived hepatic progenitor cells by growth factor defined serum-free culture conditions (Q50884321) (← links)
- Human ESC/iPSC-Derived Hepatocyte-like Cells Achieve Zone-Specific Hepatic Properties by Modulation of WNT Signaling. (Q50893427) (← links)
- Hepatocyte Nuclear Factor 4 Alpha Promotes Definitive Endoderm Differentiation from Human Induced Pluripotent Stem Cells. (Q51070593) (← links)
- Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure. (Q51557552) (← links)
- Human iPS Cell-based Liver-like Tissue Engineering at Extrahepatic Sites in Mice as a New Cell Therapy for Hemophilia B. (Q52594566) (← links)
- Optimal human iPS cell culture method for efficient hepatic differentiation (Q57070254) (← links)
- FGF signal is not required for hepatoblast differentiation of human iPS cells (Q64059879) (← links)
- Efficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies. (Q64993650) (← links)
- Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling (Q89560945) (← links)
- Comparison of commercially available media for hepatic differentiation and hepatocyte maintenance (Q89919297) (← links)
- Pharmaceutical Research on Liver Diseases Using iPS Cell and Genome Editing Technologies (Q90467030) (← links)
- Generation of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells for Cellular Medicine (Q90834973) (← links)
- Establishment of MDR1-knockout human induced pluripotent stem cell line (Q92023663) (← links)
- Pharmaceutical Research for Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cell and Genome Editing Technologies (Q92086356) (← links)
- Establishment of SLC15A1/PEPT1-Knockout Human-Induced Pluripotent Stem Cell Line for Intestinal Drug Absorption Studies (Q92345073) (← links)
- Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells (Q92953361) (← links)
- Generation of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction (Q92954289) (← links)
- In Vitro and Animal Models for SARS-CoV-2 research (Q96586470) (← links)
- Photoactivatable oncolytic adenovirus for optogenetic cancer therapy (Q97681129) (← links)
- The Structural Basis of Accelerated Host Cell Entry by SARS-CoV-2<sup>†</sup> (Q103829155) (← links)
- Introductions to the Community: Early-Career Researchers in the Time of COVID-19 (Q104070002) (← links)